London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Where is this change of position?
Always nice to see a broker change of position supported by reasoning!
Half year result expected on 25/02/2020.
China will have caused the dip. Surprised it hasnt been more to be honest.
This was the latest one.
https://www.sharesmagazine.co.uk/news/market/6744035/Broker-Forecast-Liberum-Capital-issues-a-broker-note-on-Clinigen-Group
Can't have changed that much in less than a month
Nickel have you got a link for this- or canyou copy and paste plerase!
market not liking the read one single bit !
Pleased to say that the Quantum shares I bought during the bid process have returned to profit and with the cash paid I am v happy to hold for future benefits to accrue.
I have seen some Quantum shareholders be negative on here....but they were previously in a nose diving share....we will never know if Quantum / Clin would have done better apart but the future certainly looks bigger for the combined entity.
while the announcement was strong it was selective in its metrics. EBITDA May equate to operating profit but excludes changes in capital values
Interest will be UP (fee for proleukin and acquisitions)
Depreciation Amortisation may be significant (goodwill, new ERP system, intangible asset of proleukin)
So we need to see the full picture of the financial health of the company which is perhaps why there was a muted reaction yesterday.
The company has gone through transformational change with two major acquisitions and then the significant investment in a single drug. These changes give investors cause to pause and see how they shape up.
For me the next year is pivotal and will demonstrate whether proleukin can make a positive contribution and how the acquisitions are integrated and value adding. If they are expect more significant M&A on a higher SP
it will also be any shorts having to admit defeat and close out their position. Also day traders will be selling too.
Always maintained that this is a long term investment. The acquisitions have happened. And now its time for organic growth and consolidation and integration for CLIN to realise its economies of scale.
Maybe, but you always need some people to take profit in order to move up. The MM just recycle at a higher price.
Some big sell trades showing - it’s far too early
It's about time we moved up past our all time High. The company is achieving record revenue, and making record profits.
This was obviously better than the market was expecting. A bit of the good news was already expected. So the news was definitely excellent.
VERY POSITIVE NEWS! Can't wait until the results are announced.
Does anyone know when the trading update is due? I know its soon..
I'm looking for a steady H1, with around 10% rev growth, same for profit, and net debt either the same or lower than the end of the year. If those boxes are ticked I'll be happy
This is gathering serious momentum. This will be over 1000p by the end of the month
Market seems to like the supply deal for Proleukin......
Still in the middle of the year range.
Another boost with the trading update would be nice.
Was 15 jan last year.
Looking for positive results from recent product acquisitions offset by delays to contracts as a result of Brexit delays and contingency costs.
£445k buy trade at close of business Friday. Somebody knows something methinks.
monster week for CLIN.
Price increase of 100p over the last 2 weeks and showing no signs of slowing down.
Have a good weekend folks
Not sure if it's just the election. It's been trending up for a few months.
Its probably more market factors:
1) General election result
2) The progression of negotiations between Trump and China.
CLIN will more than likely invoice in sterling and the pound has bounced.
That being said i suspect good news is ahead. My end of the year £10 prediction is looking optimistic but I don't think I was too far off.
I've noticed that too. This has been creeping up without any visible news. Unusual for this share, so looking forward to the January update.
So many BUYS going through.
Good news is ahead.